You are here:
Home > FIGO reaffirms the use of misoprostol in the prevention and treatment of post-partum haemorrhage

FIGO reaffirms the use of misoprostol in the prevention and treatment of post-partum haemorrhage

Monday, 10th September 2012

Please click here to view the Brief Statement (31 August 2012):

FIGO reaffirms the use of misoprostol in the prevention and treatment of post-partum haemorrhage

(FIGO Safe Motherhood and Newborn Health Committee):

 

Further background information:

Pathfinder International has issued a response to the recent Chu et al article in the form of a brief statement (In Defense of Misoprostol – Protecting Women’s Rights to Lifesaving Maternal Health Care), followed by a technical memo (Addressing the Controversy Surrounding Use of Misoprostol for Prevention of PPH at Community Level): http://www.pathfinder.org/news/in-defense-of-misoprostol.html 

World Congress 2015